非编码RNA介导的铁质在尿道性恶性瘤中的关键作用
Wei Li1,2,3, Liying Zheng4, Peiyue Luo1,2,3
1The First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Frontiers in immunology
|November 15, 2024
概括
非编码RNAs (ncRNAs) 调节铁亡,这是一种细胞死亡过程,在侵袭性泌尿癌中至关重要. 了解这个ncRNA-ferroptosis轴为癌症患者提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞死亡机制 细胞死亡机制
背景情况:
- 泌尿系统恶性瘤具有攻击性和转移性,构成全球健康挑战.
- 铁,铁驱动的细胞死亡,与癌症有关,但其调节机制尚未完全理解.
- 非编码RNAs (ncRNAs) 是细胞过程和癌症进展的关键调节者.
研究的目的:
- 为了澄清尿道癌症中ncRNA-ferroptosis轴的功能和机制.
- 评估与铁死相关的ncRNAs的临床意义.
- 为泌尿病恶性瘤的新型治疗策略提供见解.
主要方法:
- 文献综述和现有关于ncRNAs和泌尿癌中的ferroptosis研究的综合.
- 分析涉及微RNA (miRNA),长非编码RNA (lncRNA) 和循环RNA (circRNA) 的调节途径.
- 评估ncRNA介导的铁灭对癌细胞增殖,迁移和耐药性的影响.
主要成果:
- ncRNAs在调节尿道癌症中的铁亡中发挥着重要作用.
- 对ncRNAs的调节失调通过影响铁亡途径影响癌症进展.
- 特定的ncRNA已被确定为各种泌尿病恶性瘤中铁亡的潜在调节者.
结论:
- ncRNA-ferroptosis轴是尿道癌的发展和进展的关键决定因素.
- 向与铁亡相关的ncRNAs为开发新型癌症疗法提供了一个有希望的途径.
- 对ncRNA-ferroptosis相互作用的进一步研究可以提高我们对癌症生物学和治疗的理解.
更多相关视频
11:11Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
8.0K
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
相关概念视频
Necrosis
4.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Translation
14.6K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.6K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
